We coordinate exclusively through Shanghai's Class 3A tertiary network — China's highest hospital rating, equivalent to U.S. academic medical centers. Every recommendation is independent. We accept no commissions.
Class 3A · TertiaryInternationally accredited · affiliated with Fudan University. Strengths in general surgery, oncology, and adult reconstructive orthopedics. Largest international patient wing in the network.
Class 3A · TertiaryTop thoracic and cardiac surgery center in China — over 15,000 cardiac procedures annually. Pre-eminent in CABG, valve replacement, and thoracic oncology.
Class 3ATop neurosurgery and neurology center in China. Fudan University affiliated. Eloquent-cortex awake craniotomy pioneers.
Class 3ARenowned for cardiovascular and endocrine surgery. Shanghai Jiao Tong University. Active CAR-T cell therapy program.
Class 3ALeading liver transplant and digestive surgery center. Shanghai Jiao Tong University. 920+ transplants performed by lead unit.
Orthopedic Surgery · Joint Reconstruction
Fellowship-trained at Mayo Clinic Rochester (2010–12). Director, Adult Reconstruction at Zhongshan. Specializes in primary and revision knee/hip arthroplasty.
Cardiothoracic Surgery · CABG & Valve
Trained at Cleveland Clinic (2008–11). Chief of Adult Cardiac Surgery. Lead author on 14 publications in Annals of Thoracic Surgery.
Neurosurgery · Awake Craniotomy
Visiting fellow, Johns Hopkins (2014). Deputy Director of Neurosurgery, Huashan. Specializes in eloquent-cortex tumor resection.
Hematology · Cellular Therapy
Co-investigator on 6 CAR-T clinical trials. Trained at Memorial Sloan Kettering (2013–15). Director, Cell Therapy Unit at Ruijin.
Hepatobiliary · Transplant Surgery
Liver transplant fellowship, Pittsburgh (2011–13). Lead surgeon, Living Donor Program at Renji. Member of TTS.
Urologic Oncology · Robotic Surgery
Da Vinci certified. Trained at USC Institute of Urology (2012). Co-author of the China Urological Oncology guidelines.